Background: PRMTs are a family of proteins that either monomethylate or dimethylate the guanidino nitrogen atoms of arginine side chains. PRMT1 methylates Histone H4 on R3 and acts synergistically with p300/CBP to enhance transcriptional activation by nuclear receptors. PRMT1 also methylates a number of non-histone proteins such as the orphan nuclear receptor HNF4, components of the heterogeneous nuclear ribonucleoprotein (hnRNP) particle, interleukin enhancer-binding factor 3 (ILF3), and interferon alpha and beta receptors. This suggests roles for PRMT1 in transcriptional regulation, mRNA processing and signal transduction. PRMT1 is also a coactivator for p53, methylating histone H4 to facilitate p53-mediated transcription.
Description: Rabbit polyclonal to PRMT1
Immunogen: KLH conjugated synthetic peptide derived from PRMT1
Specificity: ·Reacts with Human, Mouse, Pig, Dog and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/100-500. Predicted Mol wt: 40 kDa;
·Immunohistochemistry (Frozen/paraffin tissue section): 1/100-500;
·Immunocytochemistry: 1/100-500;
·ELISA: 1/500;
·Optimal working dilutions must be determined by the end user.
